Financial Statements — ELAB
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 |
|---|
| Cash & Equivalents | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.48 |
| Short-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- |
| Accounts Receivable | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Inventory | 0.00 | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 | 0.00 | 0.50 |
| Total Current Assets | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 1.28 |
| Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Goodwill | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- |
| Intangible Assets | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Non-current Assets* | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 |
| Total Assets | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 1.58 |
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 |
| Total Current Liabilities | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.64 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Total Liabilities | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.75 |
| Retained Earnings | (0.03) | (0.03) | (0.02) | (0.02) | (0.01) | (0.01) | (0.01) | (0.01) | (5.87) |
| Total Stockholder Equity | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | (0.16) |
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 |
|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | 0.00 | 0.00 | 0.00 | (1.01) | 0.55 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | 0.00 | 0.00 | 0.00 | (0.34) | 0.19 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | 0.00 | 0.00 | 0.00 | (0.67) | 0.37 |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | (0.30) | 0.09 |
| Selling, General & Admin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | (1.63) | 0.66 |
| Total Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | (3.35) | 1.15 |
| Operating Income | -- | -- | -- | -0.00 | -- | -- | -- | -0.00 | -0.00 | -0.00 | -- | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | (0.01) | 0.01 |
| Net Income | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 3.14 | (0.78) |
| Basic EPS | -- | -- | -- | -- | -- | -- | -- | (0.07) | (0.08) | (0.08) | (0.08) | (0.08) |
| Diluted EPS | -- | -- | -- | -- | -- | -- | -- | (0.07) | (0.08) | (0.08) | (0.08) | (0.08) |
Cash Flow Statement
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 |
|---|
| Operating Cash Flow | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 2.16 | (2.17) |
| Capital Expenditures | -0.00 | 0.00 | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | -- | 0.01 |
| Free Cash Flow* | -0.00 | -0.00 | -0.00 | -0.00 | -- | -- | -0.00 | -0.00 | -0.00 | -0.00 | -- | (2.18) |
| Investing Cash Flow | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.01 | (0.01) |
| Financing Cash Flow | 0.01 | 0.01 | -0.00 | 0.01 | 0.00 | 0.00 | -0.00 | 0.01 | 0.00 | 0.00 | (1.49) | 1.50 |
* Derived from reported values
